
Occuity
Optical Healthcare Monitoring And Screening | Occuity | Reading.
Date | Investors | Amount | Round |
---|---|---|---|
investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 Valuation: €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
N/A | €0.0 | round | |
* | N/A | Early VC | |
Total Funding | 000k |
GBP | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | - | 32 % | - | - | - |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | (1028 %) | (2324 %) | - | - | - |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | (940 %) | (2023 %) | - | - | (545 %) |
EV | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 |
R&D % of revenue | 5 % | 13 % | - | - | - |
Source: Company filings or news article
Related Content
Occuity is a health technology startup that specializes in the development of medical devices for the screening and monitoring of chronic diseases such as diabetes, Alzheimer's, glaucoma, and myopia. The company's unique approach involves using the eye as a 'window to the health of the body', a concept they refer to as 'Oculomics'.
Occuity's innovative technology is protected by 9 international patents, covering the measurement technique and optical technology that forms the basis of their devices. Additional patents relate to the alignment and measurements within the eye. This intellectual property forms the backbone of their business model, allowing them to create unique, cutting-edge products.
The company's primary market includes high street pharmacies and care homes, where their devices can be used for non-clinical disease screening. This makes the process of detecting chronic diseases easier, cheaper, and safer, potentially revolutionizing the way these conditions are managed.
Occuity's business model is likely based on the sale of their patented devices to these establishments, as well as the potential for ongoing service or maintenance contracts. The company's work presents an exciting opportunity for a significant shift in optometry practice and chronic disease management over the next decade.
Keywords: Health Technology, Medical Devices, Chronic Disease Screening, Oculomics, Patented Technology, Non-Clinical Disease Screening, Diabetes, Alzheimer's, Glaucoma, Myopia.